Home/Filings/4/0001104659-20-139934
4//SEC Filing

Tenzing LLC 4

Accession 0001104659-20-139934

CIK 0001742927other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 8:02 PM ET

Size

9.7 KB

Accession

0001104659-20-139934

Insider Transaction Report

Form 4
Period: 2020-12-15
SAXENA PARAG
DirectorChairman of the Board10% Owner
Transactions
  • Other

    Warrants

    2020-12-15540,5000 total
    Exercise: $11.50From: 2020-12-14Exp: 2025-12-14Common Stock (540,500 underlying)
Tenzing LLC
10% Owner
Transactions
  • Other

    Warrants

    2020-12-15540,5000 total
    Exercise: $11.50From: 2020-12-14Exp: 2025-12-14Common Stock (540,500 underlying)
Nayar Rahul
DirectorChief Executive Officer10% Owner
Transactions
  • Other

    Warrants

    2020-12-15540,5000 total
    Exercise: $11.50From: 2020-12-14Exp: 2025-12-14Common Stock (540,500 underlying)
Footnotes (2)
  • [F1]In connection with the consummation of the issuer's initial business combination on December 14, 2020 (the "Business Combination"), Tenzing LLC (the "Reporting Person" or the "Sponsor") agreed to transfer 540,500 warrants to acquire shares of common stock of the issuer to a certain shareholder of the issuer in exchange for such shareholder's agreement to waive and not to exercise any right to redeem or convert shares of the issuer in connection with the Business Combination. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants became exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants.
  • [F2]These securities held by the Sponsor are beneficially owned by Rahul Nayar and Parag Saxena, the issuer's Chairman, and the managing members of the Sponsor, who have joint voting and dispositive power over the securities held by the Sponsor. Mr. Nayar and Mr. Saxena disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest.

Issuer

REVIVA PHARMACEUTICALS HOLDINGS, INC.

CIK 0001742927

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001744957

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 8:02 PM ET
Size
9.7 KB